Early research (Phase 1)Ended earlyNCT00096005
What this trial is testing
Tanespimycin and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas
Who this might be right for
Adult Grade III Lymphomatoid GranulomatosisAIDS-related Peripheral/Systemic LymphomaAnaplastic Large Cell Lymphoma+54 more
National Cancer Institute (NCI) 36